Personal information

Other IDs

Scopus Author ID: 6602683914

Activities

Collapse all

Employment (1)

University of Wisconsin–Madison: Madison, Wisconsin, US

(Medicine)
Employment
Source: Self-asserted source
Erika Heninger

Works (50 of 87)

Items per page:
Page 1 of 2

Data from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6620176.v3
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Data from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6620176
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030463
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030463.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030460
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030460.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S3 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030457.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S3 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030457
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S4 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030454.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S4 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27030454
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Data from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.c.7282277
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Data from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.c.7282277.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023184
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023184.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 2 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023181.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 2 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023181
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023178
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023178.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 4 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023175.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 4 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023175
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 5 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023172.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

FIGURE 5 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023172
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

Cancer Research Communications
2024-06-12 | Journal article
DOI: 10.1158/2767-9764.CRC-24-0248
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023169
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023169.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023166
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023166.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023163.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023163
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 4 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023160.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 4 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023160
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 5 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023157.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 5 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023157
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 6 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023154.v1
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Supplementary Figure 6 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

2024-06-12 | Preprint
DOI: 10.1158/2767-9764.26023154
Contributors: Joseph P. Gallant; Hallie M. Hintz; Gihan S. Gunaratne; Matthew T. Breneman; Emma E. Recchia; Jayden L. West; Kendahl L. Ott; Erika Heninger; Abigail E. Jackson; Natalie Y. Luo et al.
Source: check_circle
Crossref

Data from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.c.6620176.v2
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

Clinical Cancer Research
2023-06-13 | Journal article
DOI: 10.1158/1078-0432.CCR-22-1305
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507194.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507194
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507191
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507191.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S3 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507188
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S3 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507188.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S4 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507185.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S4 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-06-13 | Preprint
DOI: 10.1158/1078-0432.23507185
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Data from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-04-27 | Preprint
DOI: 10.1158/1078-0432.c.6620176.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-04-27 | Preprint
DOI: 10.1158/1078-0432.22709374
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-04-27 | Preprint
DOI: 10.1158/1078-0432.22709374.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-04-27 | Preprint
DOI: 10.1158/1078-0432.22709371
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref

Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

2023-04-27 | Preprint
DOI: 10.1158/1078-0432.22709371.v1
Contributors: Jamie M. Sperger; Kyle T. Helzer; Charlotte N. Stahlfeld; Dawei Jiang; Anupama Singh; Katherine R. Kaufmann; David J. Niles; Erika Heninger; Nicholas R. Rydzewski; Liguo Wang et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 2

Peer review (3 reviews for 2 publications/grants)

Review activity for Communications biology. (1)
Review activity for Medical oncology. (2)
How many people are using ORCID?